Biogen (BIIB) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 0.24 | 0.91 | 1.53 | 0.40 | 2.65 | 1.71 | |||
Changes by years, y/y, % | -30% | +274% | +68% | -74% | +570% | +49.9% |
Biogen. Debt/EBITDA
Biogen. Debt/EBITDA, changes, %
Biogen (BIIB) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 2.94 | 3.25 | 2.88 | 2.20 | 1.71 | 1.71 | ||
Changes by years, y/y, % | +541% | +517% | +470% | +1 093% | -42% | |||
Changes by quarters, q/q, % | +1 494% | +11% | -11% | -24% | -22% |